Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-09-12FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA granted a supplemental approval for a generic quetiapine fumarate product from Hikma Pharmaceuticals USA Inc. (ANDA 090749). The approva…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity [NA]
This entry reports an ongoing Vanderbilt University Medical Center clinical trial using accelerated DMN-targeted continuous theta-burst stim…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Skills for Talking About Cannabis for Families of Young Adults With Psychosis [NA]
ClinicalTrials.gov entry describing a research study on skills for talking about cannabis with families of young adults experiencing psychos…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia [Phase 2]
Phase 2 study evaluating the efficacy, safety, and pharmacokinetics of CPL500036 in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients [NA]
A completed clinical trial evaluated whether an interpersonal communication skills training program improves medication adherence in people …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations [NA]
A Massachusetts General Hospital clinical trial is evaluating transcranial direct current stimulation (tDCS) to enhance executive function a…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia [Phase 1]
Phase 1 clinical trial update evaluating pharmacokinetics, safety, and tolerability of different formulations and dose strengths of Quarterl…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Remediation of Visual Perceptual Impairments in People With Schizophrenia [NA]
A completed clinical trial update reports remediation of visual perceptual impairments in individuals with schizophrenia or schizoaffective …
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Energetics and Glutamate in Schizophrenia
An ongoing clinical trial funded by King's College London is examining brain energetics and glutamate signaling in schizophrenia. The study …
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Young Adults With Violent Behavior During Early Psychosis (Aim 2) [NA]
A Columbia University–sponsored clinical trial update pertains to young adults with violent behavior during early psychosis, covering schizo…
-
FDA approval · 2025-09-04FDA Approved: PALIPERIDONE — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for paliperidone (generic paliperidone). The approval makes a generic ve…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study [Phase 4]
Phase 4 Bangladesh trial update evaluating the efficacy and safety of paliperidone in schizophrenia; status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: AI-assisted Masticatory Muscle Training in Patients With Schizophrenia [NA]
An AI-assisted masticatory muscle training clinical trial in schizophrenia patients, sponsored by Kaohsiung Medical University Chung-Ho Memo…
-
FDA approval · 2025-09-03FDA Approved: PALIPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for a generic paliperidone product, expanding access to treatment for schizophrenia and schiz…
-
FDA approval · 2025-09-03FDA Approved: ZIPRASIDONE MESYLATE — Original Application (STERISCIENCE SPECIALTIES PRIVATE LIMITED)
FDA approved an original application for ziprasidone mesylate from SterisScience Specialties Private Limited, enabling a generic version of …
-
FDA approval · 2025-09-02FDA Approved: RISPERIDONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic risperidone through an Original Application for use in established indications.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Effectiveness of Breathing Therapy in Patients With Schizophrenia [NA]
A completed clinical trial evaluated the effectiveness of breathing therapy in patients with schizophrenia.
-
FDA approval · 2025-09-02FDA Approved: RISPERIDONE — Original Application (Amneal Pharmaceuticals LLC)
FDA approval of a generic risperidone original application by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis [NA]
A clinical trial is evaluating cognitive and metacognitive outcomes of VR-based avatar therapy for psychosis, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients. [NA]
This document reports an ongoing clinical trial in Taiwan evaluating a video game-facilitated group activity to improve quality of life and …
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls [NA]
This clinical trial update reports that the University of Alabama at Birmingham is recruiting participants to test the acceptability and ini…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Medial-prefrontal Enhancement During Schizophrenia Systems Imaging [NA]
A UCSF-sponsored clinical trial investigating medial-prefrontal enhancement during schizophrenia imaging is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Suicidal Behavior Among Schizophrenic Patients
A completed clinical trial update from Tanta University examining suicidal behavior in patients with schizophrenia.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia [NA]
A Muş Alparslan University clinical trial is evaluating a solution-focused psychosocial intervention to improve psychosocial adjustment and …
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia Patients
A completed clinical trial assessing physical fitness, physical activity level, depression, and quality of life in patients with bipolar dis…